Lisa A Boardman MD
Gastrointestinal Cancer
Professor, Internal Medicine, Mayo Medical School
Join to View Full Profile
200 1st St SwRochester, MN 55905
Phone+1 507-284-2511
Dr. Boardman is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Lisa Boardman is a gastroenterologist based in Rochester, MN, with a focus on gastrointestinal cancer. She completed her medical education at Wake Forest School of Medicine and further specialized in gastroenterology through a fellowship at Mayo Clinic College of Medicine and Science. Her expertise encompasses general gastroenterology, pancreatic cancer, cancer genetics, colorectal polyps, and gastrointestinal oncology. Dr. Boardman has contributed to numerous publications on topics like early-onset colon cancer and colorectal organoids. She is also the Principal Investigator in a clinical trial focused on cancer prevention in Lynch Syndrome. Her achievements include receiving CMS Meaningful Use Stage 1 and Stage 2 Certifications from GE Healthcare and Mayo Clinic.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Gastroenterology, 1994 - 1998- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1992 - 1994
University of FloridaInternship, Internal Medicine, 1991 - 1992
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1991
Certifications & Licensure
MN State Medical License 1992 - 2027
FL State Medical License 1996 - 2013
American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Centricity Enterprise, GE Healthcare, 2013-2017
- CMS Meaningful Use Stage 1 Certification Centricity Patient Online, GE Healthcare, 2013-2017
- CMS Meaningful Use Stage 1 Certification Centricity Enterprise (CE), GE Healthcare, 2013-2017
Clinical Trials
- Testing a Combination of Vaccines for Cancer Prevention in Lynch Syndrome Start of enrollment: 2023 May 08
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 5 citationsA deep learning framework for efficient pathology image analysis.Peter Neidlinger, Tim Lenz, Sebastian Foersch, Chiara M L Loeffler, Jan Clusmann
Nature Communications. 2026-07-01 - Spatial biomarker discovery via interpretable semantic learning in histopathology.Junhao Liang, Xiaofeng Jiang, Nic Gabriel Reitsam, Tim Lenz, Li Zhang
Cancer Cell. 2026-06-11 - Lower Allele Frequency of-rs2242652 in Sub-Saharan African Populations Compared With American Populations and Hepatocellular Carcinoma Risk.Perapa Chotiprasidhi, Viviana P Gonzalez Umpierre, Yvonne Ayerki Nartey, Hunter B Miller, Adrienne F Gefre
JCO Global Oncology. 2026-03-01
Journal Articles
- Natural History of Established and De Novo Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing CholangitisDavid H Bruining, Julie K Heimbach, Lisa Boardman, Laura E Raffals, Charles B Rosen, Sunanda V Kane, Kymberly D Watt, John J Poterucha, Inflammatory Bowel Diseases
Press Mentions
Can Colorectal Cancer Be Prevented?December 7th, 2022- April 2021: CRC Research & ResourcesApril 7th, 2021
Study Examines Which Polyps Lead to Colon CancerApril 7th, 2018
Grant Support
- Epigenetic mechanisms of carcinogenesis by Parvimonas micra, an oral cavity commensal turned colon cancer pathogenMAYO CLINIC ARIZONA2021–2026
- Telomere Length, Telomere Maintenance Genes And Cancer RiskNational Cancer Institute2008–2011
- Molecular Basis Of Young Onset Colorectal CancerNational Cancer Institute2004–2006
- Molecular Basis Of Young Onset Colorectal CancerNational Cancer Institute2002–2003
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
